Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites

Ruslan Rafikov; Dawn K Coletta; Lawrence J Mandarino; Olga Rafikova

doi:10.3390/jcm9010217

Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites

J Clin Med. 2020 Jan 14;9(1):217. doi: 10.3390/jcm9010217.

Authors

Ruslan Rafikov¹, Dawn K Coletta¹, Lawrence J Mandarino¹, Olga Rafikova¹

Affiliation

¹ Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.

PMID: 31947516
PMCID: PMC7019706
DOI: 10.3390/jcm9010217

Abstract

Pulmonary arterial hypertension (PAH) is an incurable, progressive disorder, and the early diagnosis and treatment of PAH are associated with increased survival [...].

Keywords: biomarkers; diabetes; metabolites; pulmonary arterial hypertension.

Grants and funding

R01HL133085/HL/NHLBI NIH HHS/United States
R24HL123767/HL/NHLBI NIH HHS/United States
R01 HL133085/HL/NHLBI NIH HHS/United States
R24 HL123767/HL/NHLBI NIH HHS/United States
R01 HL132918/HL/NHLBI NIH HHS/United States
R01HL132918/HL/NHLBI NIH HHS/United States